|
 |
|
|||||||
|
|||||||||
Diabetes 51:3577-3581, 2002
© 2002 by the American Diabetes Association, Inc.
Brief Genetics Reports |
Cellular Basis of Diabetic Nephropathy
II. The Transforming Growth Factor-ß System and Diabetic Nephropathy Lesions in Type 1 Diabetes
1 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota
2 Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Transforming growth factor-ß (TGF-ß) may be critical in the development of diabetic nephropathy (DN), and genetic predisposition is an important determinant of DN risk. We evaluated mRNA expression levels of TGF-ß system components in cultured skin fibroblasts (SFs) from type 1 diabetic patients with fast versus slow development of DN. A total of 125 long-standing type 1 diabetic patients were ranked by renal mesangial expansion score (MES) based on renal biopsy findings and diabetes duration. Patients in the highest quintile of MES who were also microalbuminuric or proteinuric (n = 16) were classified as "fast-track" for DN, while those in the lowest quintile who were also normoalbuminuric (n = 23) were classsified as "slow-track" for DN. Twenty-five normal subjects served as control subjects. SFs were cultured in medium with 25 mmol/l glucose for 36 h. SF mRNA expression levels for TGF-ß1, TGF-ß type II receptor (TGF-ß RII), thrombospondin-1, and latent TGF-ß binding protein-1 (LTBP-1) were measured by real-time RT-PCR. LTBP-1 mRNA expression was reduced in slow-track (0.99 ± 0.38) versus fast-track patients (1.65 ± 0.52, P = 0.001) and control subjects (1.41 ± 0.7, P = 0.025). mRNA levels for TGF-ß1, TGF-ß RII, and thrombospondin-1 were similar in the three groups. Reduced LTBP-1 mRNA expression in SFs from slow-track patients may reflect genetically determined DN protection and suggests that LTBP-1 may be involved in the pathogenesis of DN through the regulation of TGF-ß activity.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. L. Caramori, Y. Kim, P. Fioretto, C. Huang, S. S. Rich, M. E. Miller, G. B. Russell, and M. Mauer Cellular basis of diabetic nephropathy: IV Antioxidant enzyme mRNA expression levels in skin fibroblasts of type 1 diabetic sibling pairs Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3122 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Huang, Y. Kim, M. L. Caramori, J. H. Moore, S. S. Rich, J. C. Mychaleckyj, P. C. Walker, and M. Mauer Diabetic Nephropathy Is Associated With Gene Expression Levels of Oxidative Phosphorylation and Related Pathways Diabetes, June 1, 2006; 55(6): 1826 - 1831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zaitseva, B. J. Vollenhoven, and P. A.W. Rogers In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells Mol. Hum. Reprod., March 1, 2006; 12(3): 187 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Ewens, R. A. George, K. Sharma, F. N. Ziyadeh, and R. S. Spielman Assessment of 115 Candidate Genes for Diabetic Nephropathy by Transmission/Disequilibrium Test Diabetes, November 1, 2005; 54(11): 3305 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Mogensen Genetics and Diabetic Renal Disease: Still a big black hole Diabetes Care, May 1, 2003; 26(5): 1631 - 1632. [Full Text] [PDF]
|
|
|
|
 |
|
 F. N. Ziyadeh and K. Sharma Overview: Combating Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1355 - 1357. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |